A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is called Tecentriq or atezolizumab. It…
Category: Lung Cancer Research
Get updated information about lung cancer research here. Browse to read the articles.
Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic Oncology. The purpose behind the study…
New Promising Approach for Lung Cancer Uses Smart Nanoparticles
Lung tumors are difficult to remove using current surgical techniques due to their location in the lung. Also, there are multiple tumors which are too small to observe. They develop natural barriers…
Near-Infrared Light Treatment for A Rare Form Of Lung Cancer
Nagoya University oncologist Kazuhide Sato and team have tested the treatment for a rare type of malignant lung cancer and published its findings in the journal Cells. The team has worked to…
Study: Nicotine May Promote Brain Tumors in Lung Cancer Patients
According to a new study, researchers have found that nicotine actually promotes the spread of lung cancer cells into the brain where they can form deadly metastatic tumors. Nicotine is a non-carcinogenic…
Non-Smokers with COPD are at High Risk of Getting Lung Cancer
The most prominent factor behind getting lung cancer is smoking. In addition to smokers, non-smokers are also getting affected by this deadly disease. According to the recent study, researchers have found that…
New AI-Powered Blood Test to Detect Lung Cancer
One of the deadliest diseases is lung cancer which has affected people from all around the world. The earlier it is detected, the better chance of survival is a patient has. Medical…
Combating Small Cell Lung Cancer with Upfront Immunotherapy Options
Lung Cancer is the second most common form of cancer worldwide. Small-cell lung cancer (SCLC) represents about 10% to 15% of all lung cancers. It is a form of neuroendocrine tumor, classified…